PRA Health Sciences expanded its pharmacovigilance service to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including post-authorization safety studies (PASS) delivered by Real World Solutions.
Icon, a company creating a new paradigm for bringing clinical research to patients, has agreed to acquire PRA Health Sciences Inc. in a cash and stock transaction valued at approximately $12 billion.
The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences has announced a partnership to launch a global master clinical trial to develop new treatments for children with relapsed acute leukemia.